Back to trial details

Intake questionnaire

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Applying to NEXT Oncology Dallas · Irving, Texas

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with NSCLC Adenocarcinoma?
3. Are you able to travel to Irving for study visits?